The CDC and FDA halt use of the Johnson & Johnson vaccine due to rare, severe reactions; Mayo Clinic launches new AI-powered clinical decision support platform . Also: Omada Health rolls out new physical therapy tool.
Links to the stories:
CDC and FDA pause Johnson & Johnson vaccine over rare blood clot concerns
Mayo Clinic launches remote diagnostics platform, forms 2 new companies to support it
Omada's latest MSK tech empowers physical therapists to conduct remote appointments